The US Food and Drug Administration (FDA) has approved the first oral treatment for anaemia caused by chronic kidney disease (CKD) in adults on dialysis for at least four months: GlaxoSmithKline ...
GSK had great expectations for Blenrep after its accelerated FDA approval in 2020 as a fourth-line or later treatment for multiple myeloma, which came crashing down with the failure of the DREAMM ...
GSK’s FIRST-ENGOT-OV44 phase III clinical trial of Zejula and Jemperl in first line advanced ovarian cancer meets primary endpoint: London Saturday, December 21, 2024, 09:00 Hrs ...